Table 3.

Effects of sub−lethal exposure of sumithion on hematology (Means ± SD) at different time intervals in Silver barb. Different superscript alphabets are significantly different at P<0.05.

Parameter	Treatments	Exposure time (days)
		1	7	14	21	28
Hemoglobin	T1	11.67 ± 0.45a	12.10 ± 0.24 a	11.93 ± 0.23 a	11.97 ± 0.29 a	11.73 ± 0.19 a
	T2	11.53 ± 0.60 ab	11.33 ± 0.31 b	10.83 ± 0.29 b	10.13 ± 0.19 b	9.30 ± 0.15 b
	T3	10.90 ± 0.24 b	10.23 ± 0.52 c	10.03 ± 0.34 c	9.07 ± 0.14 c	7.97 ± 0.27 c
Hematocrit/PCV	T1	46.67 ± 0.85 a	43.05 ± 0.21 a	45.14 ± 0.25 a	44.44 ± 2.46 a	44.31 ± 3.56 a
	T2	46.52 ± 1.15 a	42.47 ± 0.73 a	38.76 ± 0.90 b	35.58 ± 0.92 b	31.00 ± 1.31 b
	T3	44.33 ± 1.38 c	33.91 ± 1.37 c	27.37 ± 1.79 c	24.88 ± 1.75 c	22.19 ± 2.19 c
RBCs (x 106/mm3)	T1	5.68 ± 0.22 a	5.50 ± 0.45 a	5.46 ± 0.46 a	5.71 ± 0.08 a	5.66 ± 0.10 a
	T2	5.27 ± 0.30 ab	4.84 ± 0.49 b	4.53 ± 0.24 b	3.96 ± 0.57 b	3.27 ± 0.41 b
	T3	5.14 ± 0.34 b	4.11 ± 0.11 c	3.23 ± 0.10 c	2.34 ± 0.06 c	2.07 ± 0.04 c
WBCs (×104/mm3)	T1	3.01 ± 0.16 a	2.96 ± 0.24 c	3.00 ± 0.14 c	2.92 ± 0.24 a	2.94 ± 0.06 c
	T2	3.08 ± 0.14 a	3.62 ± 0.19 b	3.80 ± 0.61 b	4.31 ± 0.21 b	4.42 ± 0.25 b
	T3	3.03 ± 0.15 a	4.37 ± 0.25 a	4.44 ± 0.18 a	5.16 ± 0.24 a	5.67 ± 0.11 a
MCV (μm3)	T1	82.27 ± 4.71 a	78.69 ± 6.94 b	83.19 ± 7.51 a	77.75 ± 3.36 c	78.34 ± 6.80 b
	T2	88.55 ± 6.24 a	88.45 ± 8.45 b	85.66 ± 3.76 a	91.04 ± 9.89 b	96.44 ± 14.86 a
	T3	86.57 ± 5.59 a	82.50 ± 2.36 a	84.87 ± 7.16 a	106.33 ± 7.17 a	107.47 ± 12.40 a
MCH (pg)	T1	20.54 ± 0.74 a	22.13 ± 2.18 a	21.96 ± 1.53 b	20.95 ± 0.51 c	20.74 ± 0.66 c
	T2	21.99 ± 2.32 a	23.62 ± 2.51 a	23.94 ± 1.09 b	25.99 ± 3.42 b	28.83 ± 3.53 b
	T3	21.30 ± 1.55 a	24.89 ± 0.90 a	31.09 ± 1.53 a	38.76 ± 0.79 a	38.55 ± 2.10 a
MCHC (%)	T1	25.01 ± 1.28 a	28.11 ± 0.42 b	26.44 ± 0.53 b	26.97 ± 1.10 b	26.59 ± 1.72 c
	T2	24.79 ± 1.19 a	26.68 ± 0.35 c	27.96 ± 1.12 b	28.49 ± 0.83 b	30.04 ± 1.29 b
	T3	24.60 ± 0.41 a	30.17 ± 0.32 a	36.72 ± 1.26 a	36.61 ± 2.93 a	36.09 ± 2.40 a